1. C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis. Issue 12 (14th October 2020) Authors: Lucijanic, Marko; Galusic, Davor; Krecak, Ivan; Sedinic, Martina; Soric, Ena; Holik, Hrvoje; Perisa, Vlatka; Moric Peric, Martina; Zekanovic, Ivan; Stoos-Veic, Tajana; Kusec, Rajko Journal: Leukemia & lymphoma Issue: Volume 61:Issue 12(2020) Page Start: 2969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Palpable spleen size is differently prognostic in primary and secondary myelofibrosis. Issue 4 (21st March 2023) Authors: Lucijanic, Marko; Krecak, Ivan; Soric, Ena; Galusic, Davor; Holik, Hrvoje; Perisa, Vlatka; Moric Peric, Martina; Zekanovic, Ivan; Kusec, Rajko Journal: Leukemia & lymphoma Issue: Volume 64:Issue 4(2023) Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. (August 2022) Authors: Lucijanic, Marko; Krecak, Ivan; Soric, Ena; Sabljic, Anica; Galusic, Davor; Holik, Hrvoje; Perisa, Vlatka; Moric Peric, Martina; Zekanovic, Ivan; Kusec, Rajko Journal: Leukemia research Issue: Volume 119(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗